Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation Business Practice, Small Molecules, COVID-19

COVID-19 in Brief

This article was published in our sister publication, The Small Molecule Manufacturer, which celebrates the field of small molecule drug development and manufacturing with interviews and articles focusing on success stories, equipment, and new processing techniques. Read more about The Small Molecule Manufacturer here https://themedicinemaker.com/manufacture/small-but-never-forgotten

  • Both the FDA and EMA have issued statements about the potential dangers of using hydroxychloroquine and chloroquine, two antimalarial drugs, in COVID-19 patients. There has been high interest in using the drugs as potential COVID-19 treatments. Studies are ongoing, but some early results suggest they may not be effective.
  • Indian officials have partially lifted the ban on the export of a number of medicines, including hydroxychloroquine and acetaminophen. The country initially banned the export of some drugs to quell the rising domestic concern about drug shortages. The decision to reverse the ban came after a call between Prime Minister Narendra Modi and President Donald Trump.  
  • Data published by APCO Worldwide indicates a shift in the American public’s perception of the pharma industry; 58 percent of survey respondents said US companies are more likely to create breakthrough therapies, while 68 percent were optimistic that a treatment would be developed for COVID-19. “That shows me that the public has a hopeful attitude, and almost enthusiasm, about what companies can do to solve this problem. And what a change that is from years of people basically beating up on pharmaceutical companies,” said Jack Kalavritinos, a senior director at APCO.

Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Maryam Mahdi

Associate Editor

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register